Protective coating for moisture sensitive pharmaceutical compositions
US-2024285539-A1 · Aug 29, 2024 · US
Desferrioxamine-metal complexes for the treatment of immune-related disorders
US8975294B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8975294-B2 |
| Application number | US-201013390838-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 19, 2010 |
| Priority date | Aug 19, 2009 |
| Publication date | Mar 10, 2015 |
| Grant date | Mar 10, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to methods kits and combined compositions using DFO-metal complexes, specifically, Zinc-desferrioxamine (Zn-DFO), gallium-desferrioxamine (Ga-DFO) complexes and any combinations thereof for preventing, treating, ameliorating or inhibiting an immune-related disorder, specifically, a skin-related inflammatory disorder such as psoriasis, an inflammatory respiratory condition such as asthma, and an autoimmune disease such as diabetes and any immune-related disorder.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method of treating, ameliorating, inhibiting or reducing the risk of occurrence or recurrence of a chronic or acute inflammatory-related skin pathologic condition selected from the group consisting of psoriasis, dermatitis, acne, vitiligo and wounds, comprising the step of administering to a subject in need thereof a therapeutically effective amount of at least one desferrioxamine-metal complex (DFO-metal complex), or any combination thereof or any ph…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8975294B2 cover?
- The present invention relates to methods kits and combined compositions using DFO-metal complexes, specifically, Zinc-desferrioxamine (Zn-DFO), gallium-desferrioxamine (Ga-DFO) complexes and any combinations thereof for preventing, treating, ameliorating or inhibiting an immune-related disorder, specifically, a skin-related inflammatory disorder such as psoriasis, an inflammatory respiratory co…
- Who is the assignee on this patent?
- Chevion Mordechai, Vinokur Vladimir, Berenshtein Eduard, and 4 more
- What technology area does this patent fall under?
- Primary CPC classification A61K31/28. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Mar 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).